Evaluation of safety, immunogenicity and efficacy of an attenuated rotavirus vaccine, RIX4414: a randomized, placebo-controlled trial in Latin American Infants
A live attenuated monovalent rotavirus vaccine RIX4414 was developed with a human strain of GPIA P[8] specificity to reduce the rotavirus burden in children...(AU)